Research Article

Evolution of Network Biomarkers from Early to Late Stage Bladder Cancer Samples

Table 4

(a) The pathways analysis for 152 early stage significant proteins in carcinogenesis. (b) The pathway analysis and gene set enrichment analysis of the top 20 proteins of early stage bladder cancer on () biological processes, () cellular components, and () molecular functions by NOA.
(a)

RankTermCountSymbolP value

1hsa04110:Cell cycle13YWHAZ, CREBBP, TP53, PRKDC, RB1, CDK2, HDAC2, EP300, HDAC1, PCNA, MDM2, MYC, andCUL11.50E − 14
2hsa05200:Pathways in cancer11TRAF2, EP300, HDAC2, HDAC1, CREBBP, TP53, MDM2, RB1, MYC, CDK2, and CTNNB13.51E − 07
3hsa05215:Prostate cancer7EP300, CREBBP, TP53, MDM2, RB1, CDK2, and CTNNB11.45E − 06
4hsa05220:Chronic myeloid leukemia6HDAC2, HDAC1, TP53, MDM2, RB1, and MYC1.32E − 05
5hsa04310:Wnt signaling pathway6EP300, CREBBP, TP53, MYC, CUL1, and CTNNB13.78E − 04
6hsa05222:Small cell lung cancer5TRAF2, TP53, RB1, MYC, and CDK24.04E − 04
7hsa05219:Bladder cancer4TP53, MDM2, RB1, and MYC7.24E − 04
8hsa04330:Notch signaling pathway4EP300, HDAC2, HDAC1, and CREBBP0.001008
9hsa04520:Adherens junction4EP300, CREBBP, SRC, and CTNNB10.00418
10hsa04350:TGF-beta signaling pathway4EP300, CREBBP, MYC, and CUL10.005889
11hsa05016:Huntington's disease5EP300, HDAC2, HDAC1, CREBBP, and TP530.006736
12hsa05216:Thyroid cancer3TP53, MYC, and CTNNB10.00676
13hsa04120:Ubiquitin mediated proteolysis4CUL3, MDM2, BRCA1, and CUL10.020254
14hsa05213:Endometrial cancer3TP53, MYC, and CTNNB10.020793
15hsa05214:Glioma3TP53, MDM2, and RB10.029762
16hsa04115:p53 signaling pathway3TP53, MDM2, and CDK20.034267
17hsa05218:Melanoma3TP53, MDM2, and RB10.037091
18hsa05210:Colorectal cancer3TP53, MYC, and CTNNB10.050311
19hsa04210:Apoptosis3TRAF2, IRAK1, and TP530.053574
20hsa03450:Non-homologous end-joining2XRCC6and PRKDC0.05487
21hsa04916:Melanogenesis3EP300, CREBBP, and CTNNB10.067353
22hsa04114:Oocyte meiosis3YWHAZ, CDK2, and CUL10.080913
23hsa04722:Neurotrophin signaling pathway3IRAK1, YWHAZ, and TP530.099295

The significant pathways via DAVID Bioinformatics database are selected for the 152 significant proteins in carcinogenesis. Black background indicates value > 0.05.
(b)

GO:term valueCorrected valueTerm name

() Biological processes
00442605.3E − 111.7E − 81479119342818Cellular macromolecule metabolic process
00431707.3E − 102.4E − 71479119397518Macromolecule metabolic process
00442373.6E − 81.2E − 51479119496318Cellular metabolic process
00064141.4E − 74.7E − 514791191015Translational elongation
00195381.0E − 63.2E − 41479119252813Protein metabolic process
00081521.1E − 63.6E − 41479119603318Metabolic process
00442381.7E − 65.6E − 41479119525817Primary metabolic process
00160714.4E − 60.001414791193646mRNA metabolic process
00442673.3E − 50.01101479119188310Cellular protein metabolic process
00099871.2E − 40.04061479119921619Cellular process

() Cellular components
00305297.9E − 107.8E − 816768185109Ribonucleoprotein complex
00329911.8E − 71.8E − 51676818331214Macromolecular complex
00432281.2E − 61.2E − 41676818205111Non-membrane-bounded organelle
00432321.2E − 61.2E − 41676818205111Intracellular non-membrane-bounded organelle
00058401.5E − 61.5E − 416768181965Ribosome
00058292.0E − 62.0E − 4167681812699Cytosol
00432298.3E − 68.2E − 41676818875918Intracellular organelle
00432268.5E − 68.4E − 41676818877318Organelle
00444451.7E − 50.001616768181504Cytosolic part
00332792.8E − 40.028716768181233Ribosomal subunit

() Molecular functions
00037351.0E − 61.1E − 415767191615Structural constituent of ribosome
00037231.8E − 40.019315767197556RNA binding
00051988.0E − 40.082515767196435Structural molecule activity
00316250.00130.13601576719452Ubiquitin protein ligase binding
00036780.00130.13601576719452DNA helicase activity
00045350.00240.2480157671921Poly(A)-specific ribonuclease activity
00331300.00480.4956157671941Acetylcholine receptor binding
00082010.00790.814015767191122Heparin binding
00303320.00960.9890157671981Cyclin binding
00043860.0129115767191452Helicase activity

: number of genes in reference set.
: number of genes in test set.
: number of genes annotated by given term in reference set.
: number of genes annotated by given term in test set.